Trial intelligence / Profile preview

Sevoflurane vs Propofol in Pediatric Liver Transplantation

NCT03024840Unknown

Sponsor
Tianjin First Central Hospital
Start
Dec 2016
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in liver disease and biliary atresia comparing Sevoflurane Group with Propofol Group (2 arms). Primary endpoints: S-100 beta protein, Neurospecific enolase and 2 more. Status: unknown.

02

Drugs

sevofluranepropofol
03

Conditions

liver diseasebiliary atresia

Beyond the preview

Go deeper on NCT03024840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03024840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call